Anixa Biosciences Inc Logo

Anixa Biosciences Inc

A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.

ANIX | US

Overview

Corporate Details

ISIN(s):
US45069V2034 (+1 more)
LEI:
Country:
United States of America
Address:
3150 ALMADEN EXPRESSWAY, SUITE 250, 95118 SAN JOSE

Description

Anixa Biosciences Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines for the treatment and prevention of cancer. The company's portfolio is centered on two main platforms: a therapeutics program and a vaccine program. The therapeutics portfolio features a Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy, which genetically engineers a patient's own immune cells to target and destroy solid tumors. The vaccine portfolio includes preventative and therapeutic candidates for various cancers, with a primary focus on breast and ovarian cancer, and discovery programs for lung, colon, and prostate cancer. Anixa aims to address critical unmet needs in oncology through these innovative approaches.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 10:13
4
English 7.9 KB
2025-10-01 02:15 English 5.2 KB
2025-09-10 19:25
S-3
English 316.6 KB
2025-09-10 18:30
10-Q
English 949.3 KB
2025-08-04 11:00 English 6.7 KB
2025-07-31 11:00 English 6.7 KB
2025-07-21 10:30 English 6.6 KB
2025-07-15 08:03 English 6.7 KB
2025-07-14 10:40 English 6.7 KB
2025-06-06 19:36 English 8.2 KB
2025-06-05 11:11 English 6.7 KB
2025-05-28 18:20
10-Q
English 864.8 KB
2025-03-21 17:15 English 18.0 MB
2025-03-11 17:20 English 932.2 KB
2025-02-06 17:15 English 487.1 KB

Automate Your Workflow. Get a real-time feed of all Anixa Biosciences Inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anixa Biosciences Inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Anixa Biosciences Inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.